ROBERT SIEGEL, host: In 2004, Merck pulled its painkiller Vioxx from the market. The drug was causing heart problems, strokes and deaths among patients in a large study that was under way at the time.

In March, the National Transportation Safety Board (NTSB) released a brief statement stating the results of a study it conducted into the relative safety of general aviation airplanes equipped with ...

In a recent study published in The Lancet, researchers performed an implementation study of a 12-gene pharmacogenetic panel across seven European countries to investigate whether a gene-drug ...